Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-02-25 @ 2:41 AM
Study NCT ID:
NCT00526968
Status:
COMPLETED
Last Update Posted:
2008-02-18
First Post:
2007-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function
Sponsor:
Evotec Neurosciences GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EVT 101/1002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Hermann Fuder, Senior VP, Clinical Development
Old Organization:
Evotec Neurosciences GmbH
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |